Thomas Dschietzig

2.5k total citations
65 papers, 1.9k citations indexed

About

Thomas Dschietzig is a scholar working on Public Health, Environmental and Occupational Health, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thomas Dschietzig has authored 65 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Public Health, Environmental and Occupational Health, 15 papers in Physiology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thomas Dschietzig's work include Pregnancy-related medical research (29 papers), Nitric Oxide and Endothelin Effects (12 papers) and Pulmonary Hypertension Research and Treatments (6 papers). Thomas Dschietzig is often cited by papers focused on Pregnancy-related medical research (29 papers), Nitric Oxide and Endothelin Effects (12 papers) and Pulmonary Hypertension Research and Treatments (6 papers). Thomas Dschietzig collaborates with scholars based in Germany, Austria and United States. Thomas Dschietzig's co-authors include Gert Baumann, Karl Stangl, Cornelia Bartsch, Christoph Richter, Michael Laule, Franz Paul Armbruster, Konstantin Alexiou, Roger J. Summers, Karl Stangl and Elaine Unemori and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Thomas Dschietzig

64 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Dschietzig Germany 26 1.0k 430 278 227 213 65 1.9k
Pi‐Hua Liu Taiwan 18 162 0.2× 195 0.5× 269 1.0× 220 1.0× 184 0.9× 46 1.3k
Christopher H.E. Imray United Kingdom 21 219 0.2× 170 0.4× 157 0.6× 182 0.8× 215 1.0× 56 1.4k
Jeb S. Orr United States 18 175 0.2× 357 0.8× 124 0.4× 497 2.2× 87 0.4× 21 1.2k
Christopher J. Womack United States 18 164 0.2× 139 0.3× 156 0.6× 196 0.9× 107 0.5× 47 956
Per‐Arne Lundberg Sweden 23 347 0.3× 396 0.9× 331 1.2× 333 1.5× 156 0.7× 59 2.4k
Michael World United Kingdom 20 131 0.1× 1.1k 2.6× 334 1.2× 509 2.2× 201 0.9× 41 2.4k
Timo Peter Netherlands 17 265 0.3× 683 1.6× 289 1.0× 1.6k 7.1× 78 0.4× 19 2.9k
Lajos Bogár Hungary 22 104 0.1× 178 0.4× 154 0.6× 112 0.5× 204 1.0× 87 1.2k
G.E. Plante Canada 16 164 0.2× 853 2.0× 192 0.7× 208 0.9× 197 0.9× 56 1.6k
Mohamed Ibrahim Netherlands 13 150 0.1× 679 1.6× 247 0.9× 844 3.7× 287 1.3× 28 2.0k

Countries citing papers authored by Thomas Dschietzig

Since Specialization
Citations

This map shows the geographic impact of Thomas Dschietzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Dschietzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Dschietzig more than expected).

Fields of papers citing papers by Thomas Dschietzig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Dschietzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Dschietzig. The network helps show where Thomas Dschietzig may publish in the future.

Co-authorship network of co-authors of Thomas Dschietzig

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Dschietzig. A scholar is included among the top collaborators of Thomas Dschietzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Dschietzig. Thomas Dschietzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kleber, Marcus E., Brigitte M. Winklhofer‐Roob, Wilfried Renner, et al.. (2024). Haptoglobin polymorphism, vitamin E and mortality: the Ludwigshafen Risk and Cardiovascular Health Study. BMJ Nutrition Prevention & Health. 7(2). 296–303.
2.
Dschietzig, Thomas, et al.. (2024). Periodic injections of Relaxin 2, its pharmacokinetics and remodeling of rat hearts. Biochemical Pharmacology. 223. 116136–116136. 1 indexed citations
3.
Dschietzig, Thomas, et al.. (2023). Cardiovascular effects of relaxin-2: therapeutic potential and future perspectives. Clinical Research in Cardiology. 113(8). 1137–1150. 7 indexed citations
4.
Bathgate, Ross A. D., Thomas Dschietzig, Andrew L. Gundlach, Michelle L. Halls, & Roger J. Summers. (2021). Relaxin family peptide receptors in GtoPdb v.2021.3. IUPHAR/BPS Guide to Pharmacology CITE. 2021(3). 1 indexed citations
5.
Zeng, Shufei, Uwe Querfeld, Martina Feger, et al.. (2020). Relationship between GFR, intact PTH, oxidized PTH, non‐oxidized PTH as well as FGF23 in patients with CKD. The FASEB Journal. 34(11). 15269–15281. 16 indexed citations
6.
Dschietzig, Thomas. (2019). Relaxin-2 for heart failure with preserved ejection fraction (HFpEF): Rationale for future clinical trials. Molecular and Cellular Endocrinology. 487. 54–58. 16 indexed citations
7.
Dschietzig, Thomas, Felix Boschann, Franz Paul Armbruster, et al.. (2019). Plasma Kynurenine Predicts Severity and Complications of Heart Failure and Associates with Established Biochemical and Clinical Markers of Disease. Kidney & Blood Pressure Research. 44(4). 765–776. 27 indexed citations
8.
Meinitzer, Andreas, et al.. (2017). Homoarginine—A prognostic indicator in adolescents and adults with complex congenital heart disease?. PLoS ONE. 12(9). e0184333–e0184333. 8 indexed citations
9.
Reichetzeder, Christoph, et al.. (2017). Pre-Interventional Kynurenine Predicts Medium-Term Outcome after Contrast Media Exposure Due to Coronary Angiography. Kidney & Blood Pressure Research. 42(2). 244–256. 9 indexed citations
10.
Chaykovska, Lyubov, et al.. (2017). ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography. Medicine. 96(6). e6065–e6065. 12 indexed citations
11.
Sarwar, Mohsin, Xiao‐Jun Du, Thomas Dschietzig, & Roger J. Summers. (2016). The actions of relaxin on the human cardiovascular system. British Journal of Pharmacology. 174(10). 933–949. 62 indexed citations
12.
Konishi, Masaaki, Nicole Ebner, Jochen Springer, et al.. (2016). Impact of Plasma Kynurenine Level on Functional Capacity and Outcome in Heart Failure　― Results From Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF) ―. Circulation Journal. 81(1). 52–61. 34 indexed citations
13.
Halls, Michelle L., Ross A. D. Bathgate, Steve W. Sutton, Thomas Dschietzig, & Roger J. Summers. (2015). International Union of Basic and Clinical Pharmacology. XCV. Recent Advances in the Understanding of the Pharmacology and Biological Roles of Relaxin Family Peptide Receptors 1–4, the Receptors for Relaxin Family Peptides. Pharmacological Reviews. 67(2). 389–440. 102 indexed citations
14.
Dschietzig, Thomas. (2014). Myostatin — From the Mighty Mouse to cardiovascular disease and cachexia. Clinica Chimica Acta. 433. 216–224. 47 indexed citations
15.
Dschietzig, Thomas. (2014). Recombinant Human Relaxin-2: (How) Can a Pregnancy Hormone Save Lives in Acute Heart Failure?. American Journal of Cardiovascular Drugs. 14(5). 343–355. 8 indexed citations
16.
Dschietzig, Thomas, et al.. (2010). The Positive Inotropic Effect of Relaxin-2 in Human Atrial Myocardium is Preserved in End-Stage Heart Failure: Role of Gi-Phosphoinositide-3 Kinase Signaling. Journal of Cardiac Failure. 17(2). 158–166. 38 indexed citations
17.
Dschietzig, Thomas, Cornelia Bartsch, Gert Baumann, & Karl Stangl. (2006). Relaxin—a pleiotropic hormone and its emerging role for experimental and clinical therapeutics. Pharmacology & Therapeutics. 112(1). 38–56. 85 indexed citations
18.
Dschietzig, Thomas, et al.. (2005). Myocardial Relaxin Counteracts Hypertrophy in Hypertensive Rats. Annals of the New York Academy of Sciences. 1041(1). 441–443. 28 indexed citations
19.
Dschietzig, Thomas, et al.. (2001). Flow-Induced Pressure Differentially Regulates Endothelin-1, Urotensin II, Adrenomedullin, and Relaxin in Pulmonary Vascular Endothelium. Biochemical and Biophysical Research Communications. 289(1). 245–251. 47 indexed citations
20.
Stangl, Karl, Ingolf Cascorbi, Verena Stangl, et al.. (2000). Hyperhomocysteinaemia and adverse events complicating coronary catheter interventions. International Journal of Cardiology. 76(2-3). 211–217. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pi‐Hua Liu Breakdown of academic impact, for papers by Christopher H.E. Imray Breakdown of academic impact, for papers by Jeb S. Orr Breakdown of academic impact, for papers by Christopher J. Womack Breakdown of academic impact, for papers by Per‐Arne Lundberg Breakdown of academic impact, for papers by Michael World Breakdown of academic impact, for papers by Timo Peter Breakdown of academic impact, for papers by Lajos Bogár Breakdown of academic impact, for papers by G.E. Plante Breakdown of academic impact, for papers by Mohamed Ibrahim
Rankless by CCL
2026